HK1204629A1 - 用免疫球蛋白治療粘膜炎 - Google Patents

用免疫球蛋白治療粘膜炎

Info

Publication number
HK1204629A1
HK1204629A1 HK15105090.1A HK15105090A HK1204629A1 HK 1204629 A1 HK1204629 A1 HK 1204629A1 HK 15105090 A HK15105090 A HK 15105090A HK 1204629 A1 HK1204629 A1 HK 1204629A1
Authority
HK
Hong Kong
Prior art keywords
mucositis
immunoglobulin
treatment
Prior art date
Application number
HK15105090.1A
Other languages
English (en)
Inventor
Christoph Aebi
Sonja Christina Lueer
Alexander Schaub
Sylvia Miescher
Adrian Zuercher
Cedric Pierre Vonarburg
Original Assignee
Csl Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Ag filed Critical Csl Behring Ag
Publication of HK1204629A1 publication Critical patent/HK1204629A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK15105090.1A 2012-03-09 2015-05-28 用免疫球蛋白治療粘膜炎 HK1204629A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12158939.4A EP2636683A1 (en) 2012-03-09 2012-03-09 Treatment of mucositis with Immunoglobulin
PCT/EP2013/054722 WO2013132063A1 (en) 2012-03-09 2013-03-08 Treatment of mucositis with immunoglobulin

Publications (1)

Publication Number Publication Date
HK1204629A1 true HK1204629A1 (zh) 2015-11-27

Family

ID=45808320

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105090.1A HK1204629A1 (zh) 2012-03-09 2015-05-28 用免疫球蛋白治療粘膜炎

Country Status (11)

Country Link
US (1) US9546209B2 (zh)
EP (2) EP2636683A1 (zh)
JP (1) JP6238910B2 (zh)
KR (1) KR102120620B1 (zh)
CN (1) CN104254543B (zh)
AU (1) AU2013201394B2 (zh)
CA (1) CA2865810C (zh)
DK (1) DK2822966T3 (zh)
ES (1) ES2660157T3 (zh)
HK (1) HK1204629A1 (zh)
WO (1) WO2013132063A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2636681A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
CA2866634C (en) 2012-03-09 2022-07-19 Csl Behring Ag Compositions comprising secretory-like immunoglobulins
EP2636684A1 (en) * 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
EP4235448A3 (en) 2016-11-10 2023-10-11 Becton, Dickinson and Company Timeline system for monitoring a culture media protocol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8063798A (en) * 1997-06-19 1999-01-04 Regents Of The University Of California, The Secretory immunoglobulin produced by single cells and methods for making and using same
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
EP2725035A1 (en) * 2007-10-02 2014-04-30 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract

Also Published As

Publication number Publication date
EP2822966B1 (en) 2017-11-29
EP2636683A1 (en) 2013-09-11
AU2013201394A1 (en) 2013-09-26
US9546209B2 (en) 2017-01-17
JP6238910B2 (ja) 2017-11-29
US20150030613A1 (en) 2015-01-29
CA2865810A1 (en) 2013-09-12
KR20140145587A (ko) 2014-12-23
AU2013201394B2 (en) 2015-09-03
WO2013132063A1 (en) 2013-09-12
ES2660157T3 (es) 2018-03-21
EP2822966A1 (en) 2015-01-14
CN104254543A (zh) 2014-12-31
CN104254543B (zh) 2018-06-05
DK2822966T3 (en) 2018-02-26
JP2015513554A (ja) 2015-05-14
CA2865810C (en) 2022-09-06
KR102120620B1 (ko) 2020-06-10

Similar Documents

Publication Publication Date Title
HK1202672A1 (zh) 因素實驗條件的診斷過程
EP2878520A4 (en) BORDER SECTION STRUCTURE OF A VEHICLE
GB201506561D0 (en) Treatment of amblyopia
ZA201406082B (en) Use of ccr3-inhibitors
HK1209767A1 (zh) 艾杜糖- -硫酸酯酶的純化
HK1211986A1 (zh) 血小板靶向治療
EP2881113A4 (en) NEW APPLICATION OF POGOSTONE
HK1206283A1 (zh) 用抗- 抗體治療多發性硬化症
HK1204629A1 (zh) 用免疫球蛋白治療粘膜炎
HK1188366A2 (en) One type of massager
GB201309274D0 (en) Treatment Of Fuel
EP2892529A4 (en) USES OF (-) - PERHEXILINE
EP3560952C0 (en) VARIANT OF BPIFB4 PROTEIN
EP2822594A4 (en) METHODS OF TREATMENT WITH ANTI-ANGIOPOIETIN-2 ANTIBODIES
EP2852411A4 (en) ANTI-CCL2 ANTIBODIES FOR THE TREATMENT OF SCLEROMERMIA
GB201207907D0 (en) Treatment of depression
ZA201601626B (en) Treatment of gases
HK1210421A1 (zh) 孕甾- -烯- -炔- -酮用於治療抑鬱症的用途
ES1076665Y (es) Transportador manual de paellas
GB201221118D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201218263D0 (en) Treatment of autism
GB201206324D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment